Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023
LUND, Sweden, April 4, 2023 /PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today...
Source: europapress.es
📰 Phderic Van Cutsem News
Phderic Van Cutsem News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Phderic Van Cutsem. Real-time updates on events, politics, business and more.